TAG:
quest diagnostics and labcorp
CYP450 Testing To Have Major Clinical Impact
By Robert Michel | From the Volume XIII No. 5 – April 10, 2006 Issue
CEO SUMMARY: Pharmacogenomics, companion diagnostics, “personalized prescription drug therapy”—by any name, use of molecular diagnostics to guide clinicians in the prescribing and dosing of drugs is about to expand exponentially. Some experts predict that CYP450 testing alone will …
Picking Top Ten Stories Of 2005 for Lab Industry
By Robert Michel | From the Volume XII No. 17 – December 5, 2005 Issue
CEO SUMMARY: THE DARK REPORT offers its pic…
Our Tenth Anniversary Serving Your Needs
By Robert Michel | From the Volume XII No. 14 – October 3, 2005 Issue
CEO SUMMARY: It was on September 25, 1995 that the first issue of THE DARK REPORT was published. The laboratory industry was in financial turmoil. There was widespread consolidation in both the commercial lab sector and among hospital laboratories. Reimbursement for lab testing services w…
AmeriPath Will Acquire Specialty Laboratories
By Robert Michel | From the Volume XII No. 14 – October 3, 2005 Issue
CEO SUMMARY: It’s a surprise to most lab industry observers. AmeriPath, a company built around 400 anatomic pathologists working mostly in community hospitals, is acquiring a national reference/esoteric testing company. However, this deal may be better understood by looking at the motiv…
Sonic HealthCare In US: How Will Market Change?
By Robert Michel | From the Volume XII No. 13 – September 12, 2005 Issue
CEO SUMMARY: LabOne, Inc.’s acquisition by Quest Diagnostics Incorporated, announced in early August, removes, as a competitor, a lab company that was growing and beginning to credibly challenge the two blood brothers. Just weeks later, Sonic Healthcare Ltd.’s purchase of Clinical Pat…
For Quest and LabCorp, The Story is “Molecular”
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
CEO SUMMARY: Wall Street likes the potential of molecular diagnostics to infuse new revenues and operating profits into the laboratory industry. That is one reason Quest Diagnostics Incorporated and Laboratory Corporation of America are assertively seeking exclusive access to new molecula…
DOJ Sends Subpoenas To Quest & LabCorp
By Robert Michel | From the Volume XII No. 9 – June 20, 2005 Issue
CEO SUMMARY: In Newark, New Jersey, the Office of the U.S. Attorney served subpoenas to each of the two blood brothers, seeking information on “capitation and risk-sharing arrangements with government and private payers for the years 1993 through 1999.” At this point, little is known …
Year-end Financials Released For Quest, LabCorp & LabOne
By Robert Michel | From the Volume XII No. 5 – March 28, 2005 Issue
In RECENT WEEKS, public laboratory companies have released earnings reports for the year-ending December 31, 2004. It was generally a good year for the three largest lab companies that have a major emphasis on providing lab testing services to office-based physicians. In this year’s review, THE DA…
Are Two Blood Brothers Using Economic Clout?
By Robert Michel | From the Volume X No. 10 – July 28, 2003 Issue
CEO SUMMARY: Quest Diagnostics Incorporated and Laboratory Corporation of America now dominate the national marketplace for testing referred by physicians’ offices. Release of their second quarter earnings reports provides the first look at their performance following the acquisitions i…
Lab Acquisitions in 2002 Changed National Market
By Robert Michel | From the Volume X No. 8 – June 16, 2003 Issue
NEVER IN THE PAST THREE DECADES has there been so few laboratory companies—public and private—competing to offer lab testing services to office-based physicians. At the end of 2002, THE DARK REPORT’S annual ranking of public laboratory companies showed just 11 firms. Of these, two (Uni…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized